This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Meghan L Good: Innovator in Hematopoietic Progenitor Cell Research
Introduction
Meghan L Good is a prominent inventor based in Derwood, MD (US). She has made significant contributions to the field of hematopoietic progenitor cell research. Her innovative work has led to the development of methods that have the potential to impact medical treatments.
Latest Patents
Meghan L Good holds 1 patent titled "Methods of preparing hematopoietic progenitor cells in vitro." This patent discloses methods for preparing CD34+CD43+ hematopoietic progenitor cells (HPC) in vitro. Additionally, it outlines methods for differentiating these progenitor cells into hematopoietic lineage cells. The patent also includes methods for treating or preventing conditions in mammals, such as cancer.
Career Highlights
Meghan L Good is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to focus on groundbreaking research in the field of hematopoietic progenitor cells.
Collaborations
Some of her notable coworkers include Raul E Vizcardo and Naritaka Tamaoki. Their collaborative efforts contribute to the advancement of research in hematopoietic progenitor cells.
Conclusion
Meghan L Good's innovative research and patent contributions are paving the way for advancements in medical treatments related to hematopoietic progenitor cells. Her work exemplifies the impact of dedicated inventors in the field of health and medicine.